
    
      This is a retrospective, multi-site study involving chart reviews of subjects who have
      received an Ultherapy treatment along with Radiesse®, Xeomin®, and/or Belotero® Balance
      within six months apart in the face and/or neck areas. Enrolled subjects will have received
      an Ultherapy treatment along with botulinum toxin A and/or filler treatment(s) within the
      last two years and with filler and toxin treatment occurring within 6 months before or after
      Ultherapy.
    
  